This is the first report to monitor the sPD-L1 levels in peripheral blood during perioperative periods in patients with operable NSCLC, and the data demonstrated that peripheral sPD-L1 levels were elevated 1 month after surgery despite the absence of tumors. The gene discussed is SPDL1; the disease is non-small cell lung carcinoma.